INVENTIVA (EPA:IVA) | Finanzwire

PRESS RELEASE

published on 07/05/2024 at 22:00, 1 year 9 months ago

Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position
Inventiva updates on its clinical program evaluating lanifibranor for MASH/NASH, with positive recruitment and financial outlook. New patents strengthen the company's position

Financial Position Clinical Program Inventiva Lanifibranor MASH/NASH
BRIEF

published on 06/21/2024 at 22:05, 1 year 10 months ago

Results of the Combined Shareholders' General Meeting of June 20, 2024

Shareholders' Meeting Resolutions Votes Inventiva
PRESS RELEASE

published on 06/21/2024 at 22:05, 1 year 10 months ago

Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024
Description of the share repurchase program authorized by the Ordinary General Meeting of 20 June 2024 by Inventiva SA. Details on objectives, maximum capital proportion, and allocation of treasury shares presented

Liquidity Agreement Ordinary General Meeting AMF General Regulations Share Repurchase Program Inventiva SA
PRESS RELEASE

published on 06/21/2024 at 22:00, 1 year 10 months ago

Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024
Inventiva announces voting results of Combined Shareholders' Meeting held on June 20, 2024. All resolutions, except 30th, were adopted. Details of votes and quorum provided

Voting Results Quorum Combined Shareholders' Meeting Resolutions Adopted Inventiva
BRIEF

published on 05/30/2024 at 08:35, 1 year 11 months ago

Inventiva: Status of voting rights and shares as of May 13, 2024

Euronext Paris Share Capital Voting Rights Financial Transparency Inventive
BRIEF

published on 05/30/2024 at 08:35, 1 year 11 months ago

Inventiva Combined General Meeting of June 20, 2024 - Conditions for making preparatory documents available

Shareholders Biopharmaceutical General Assembly Preparatory Documents Inventive
BRIEF

published on 05/27/2024 at 09:12, 1 year 11 months ago

Crossing threshold for INVENTIVA

Capital Transfer Of Shares Crossing Threshold Inventiva UBS Group AG
BRIEF

published on 05/21/2024 at 22:05, 1 year 11 months ago

Inventiva Releases First Quarter 2024 Financial Results and Business Updates

Financial Results Treasury BEI Inventive NATiV3 Clinical Trials
PRESS RELEASE

published on 05/21/2024 at 22:00, 1 year 11 months ago

Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update
Inventiva reports 2024 First Quarter Financial Information and corporate update, including cash, deposits, and clinical trial progress. Company actively seeking financing options

Financial Information Deposits Clinical Trial Cash Inventiva

Published on 05/01/2026 at 04:00, 10 minutes ago

Jericho Energy Ventures Announces Short Delay in Filing of 2025 Annual Financial Statements
Published on 05/01/2026 at 03:25, 45 minutes ago

McEwen Inc. and Golden Lake Exploration Inc. Announce Closing of Arrangement
Published on 05/01/2026 at 02:55, 1 hour 15 minutes ago

GLG Life Tech Corporation Reports 2025 Annual & Fourth Quarter Financial Results
Published on 05/01/2026 at 01:00, 3 hours 10 minutes ago

PPX Mining Announces Grant of Stock Options, Restricted Share Units and Deferred Share Units
Published on 05/01/2026 at 00:45, 3 hours 25 minutes ago

Inventus Announces Closing of $2.5 Million Non-Brokered Flow-Through Financing

View all ACCESSWIRE

Published on 04/30/2026 at 23:39, 4 hours 31 minutes ago

Anemoi International Ltd: Final Results For Year Ended 31 December 2025
Published on 04/30/2026 at 22:35, 5 hours 35 minutes ago

Curaleaf Completes Buyout of Remaining Stake in Germany's Four 20 Pharma
Published on 04/30/2026 at 22:04, 6 hours 6 minutes ago

Interim individual financial statements for the period ending on March 31, 2026 of Sirma Group Holding JSC
Published on 04/30/2026 at 19:00, 9 hours 10 minutes ago

DOUGLAS Group grows sales in Q2 and updates full-year guidance on adjusted EBITDA
Published on 04/30/2026 at 19:00, 9 hours 10 minutes ago

BioVersys announces approval of all Board Proposals at Annual General Meeting of Shareholders

View all EQS

Published on 04/30/2026 at 20:00, 8 hours 9 minutes ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 8 hours 54 minutes ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 9 hours 10 minutes ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 10 hours ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 10 hours 10 minutes ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News